Pre-Exposure Prophylaxis

"Pre-Exposure Prophylaxis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A method of disease prevention (abbreviated PrEP) which involves the administration of drugs to at-risk persons who have not been exposed to the disease-causing agent.

Descriptor ID	D065129
MeSH Number(s)	N02.421.726.758.655 N06.850.780.680.655
Concept/Terms	Pre-Exposure Prophylaxis Pre-Exposure Prophylaxis Pre Exposure Prophylaxis Pre-Exposure Prophylaxi Prophylaxi, Pre-Exposure Prophylaxis, Pre-Exposure Pre-Exposure Prophylaxis (PrEP) Pre Exposure Prophylaxis (PrEP) Pre-Exposure Prophylaxi (PrEP) Prophylaxi, Pre-Exposure (PrEP) Prophylaxis, Pre-Exposure (PrEP)

Below are MeSH descriptors whose meaning is more general than "Pre-Exposure Prophylaxis".

Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Preventive Health Services [N02.421.726]
Primary Prevention [N02.421.726.758]
Pre-Exposure Prophylaxis [N02.421.726.758.655]
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Primary Prevention [N06.850.780.680]
Pre-Exposure Prophylaxis [N06.850.780.680.655]

Below are MeSH descriptors whose meaning is related to "Pre-Exposure Prophylaxis".

Below are MeSH descriptors whose meaning is more specific than "Pre-Exposure Prophylaxis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pre-Exposure Prophylaxis" by people in this website by year, and whether "Pre-Exposure Prophylaxis" was a major or minor topic of these publications.

Bar chart showing 49 publications over 11 distinct years, with a maximum of 11 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2014	1	0	1
2016	4	0	4
2017	2	0	2
2018	1	0	1
2019	2	0	2
2020	1	1	2
2021	8	3	11
2022	6	0	6
2023	10	0	10
2024	8	0	8
2025	2	0	2

Below are the most recent publications written about "Pre-Exposure Prophylaxis" by people in Profiles.

Humphrey TJL, Qian W, Chen-Xu M, Dowling F, Gatley K, Adhikari R, Hensman T, Stockley L, Bassi A, Bathla N, Dasgupta I, Dosanjh DPS, Jellings? M, S?rensen P, Jensen ML, Callesen AW, Bradley JR, Jha V, Sommer MOA, Hiemstra TF, Smith RM. Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial. BMC Infect Dis. 2025 Feb 11; 25(1):204.

View in: PubMed
Mi Y, Wiginton JM, Murray SM, Lucas I, Valentine-Graves M, Dean LT, Willie TC, Willis K, Sanchez T, Baral S, Rao A. Association between homelessness and PrEP uptake among men who have sex with men: Results from the American Men's Internet Survey, 2017-2021. Soc Sci Med. 2025 02; 366:117674.

View in: PubMed
Dawit R, Goedel WC, Chang HY, Nunn AS, Chan PA, Doshi JA, Dean LT. County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018. AIDS Behav. 2025 Apr; 29(4):1089-1095.

View in: PubMed
Atuhaire B, Muteebwa L, Nabunya R, Muhindo R, Ngabirano TD, Osingada CP, Muwanguzi PA. Brief Communication:?Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university. AIDS Res Ther. 2024 12 20; 21(1):95.

View in: PubMed
Keddem S, Broderick K, Van Epps P, Roberts CB, Chhatre S, Beste LA. Brief communication: The cohort of women prescribed HIV PrEP at the Veterans Health Administration. AIDS Res Ther. 2024 11 01; 21(1):78.

View in: PubMed
Bakre S, Chang HY, Doshi JA, Goedel WC, Saberi P, Chan PA, Nunn A, Dean LT. Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments. JAMA Intern Med. 2024 10 01; 184(10):1204-1211.

View in: PubMed
Dawit R, Predmore Z, Raifman J, Chan PA, Dean LT. Perceived Versus Actual Costs of HIV Pre-Exposure Prophylaxis Among Gay, Bisexual, and Other Men Who Have Sex with Men in the United States. AIDS Patient Care STDS. 2024 10; 38(10):468-476.

View in: PubMed
Keddem S, Thatipelli S, Caceres O, Roder N, Momplaisir F, Cronholm P. Barriers and Facilitators to Long-Acting Injectable HIV Pre-Exposure Prophylaxis Implementation in Primary Care Since Its Approval in the United States. J Acquir Immune Defic Syndr. 2024 04 01; 95(4):370-376.

View in: PubMed
Keddem S, Frye V, Davis A, Koblin BA, Tieu HV, Lipsky RK, Nandi V, Teitelman AM. The Moderating Effects of HIV Relevant Factors on the Relationship Between Intimate Partner Violence and Intention to Start HIV Pre-exposure Prophylaxis (PrEP) Among Cisgender Women. Arch Sex Behav. 2024 04; 53(4):1531-1539.

View in: PubMed
Dean LT, Nunn AS, Chang HY, Bakre S, Goedel WC, Dawit R, Saberi P, Chan PA, Doshi JA. Estimating The Impact Of Out-Of-Pocket Cost Changes On Abandonment Of HIV Pre-Exposure Prophylaxis. Health Aff (Millwood). 2024 01; 43(1):36-45.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement